What is the recommended dose of Montelukast (Singulair) for a 16-year-old female with asthma or allergic rhinitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Montelukast Dosing for a 16-Year-Old Female

The recommended dose of montelukast for a 16-year-old female is 10 mg once daily, taken orally in the evening for asthma or at any consistent time for allergic rhinitis. 1

Standard Dosing by Age

  • Adolescents 15 years and older receive the adult dose of 10 mg once daily 1
  • This applies to both asthma and allergic rhinitis indications 1
  • The 10-mg film-coated tablet formulation is appropriate for this age group 2

Administration Timing

  • For asthma: Take once daily in the evening 1
  • For allergic rhinitis: Take once daily at approximately the same time each day (timing less critical) 1
  • For exercise-induced bronchoconstriction: Take at least 2 hours before exercise, but not more than once in 24 hours 1

Important Clinical Context

Montelukast is not a first-line agent for either asthma or allergic rhinitis. For allergic rhinitis specifically, intranasal corticosteroids demonstrate superior efficacy and should be recommended over montelukast for initial treatment 3. The evidence clearly shows clinically meaningful greater symptom reduction with intranasal corticosteroids compared to montelukast 3.

When Montelukast May Be Appropriate

  • Patients with concurrent asthma and allergic rhinitis may benefit from montelukast as it addresses both conditions simultaneously, though it remains suboptimal as monotherapy for either condition 4, 5
  • Patients who refuse or cannot tolerate intranasal corticosteroids may use montelukast as an alternative despite its lesser efficacy 3
  • As add-on therapy when intranasal corticosteroids alone provide inadequate control 4

Pharmacokinetic Considerations

  • The 10-mg dose was selected based on dose-ranging studies showing it produces maximal improvement in airway function and patient-reported outcomes 2
  • Clinical benefits begin by the second day of daily treatment, which is slower than antihistamines 5
  • The medication provides continuous control rather than acute symptom relief 5

Administration Instructions

  • May be taken with or without food 1
  • For asthma patients: Continue taking daily even when asymptomatic 1
  • Do not use for acute asthma attacks—always have rescue inhaler available 1
  • If already taking daily montelukast for chronic asthma or allergic rhinitis, do not take an additional dose for exercise-induced bronchoconstriction 1

Critical Safety Considerations

Neuropsychiatric adverse effects have been reported with montelukast, including agitation, aggressive behavior, depression, anxiety, hallucinations, suicidal thoughts and actions, and sleep disturbances 1. Patients and families should be counseled to report any behavior or mood-related changes immediately 1, 6.

Related Questions

Is it safe to take Montelukast (Singulair) twice a day?
What is the recommended dose of Montek LC (montelukast) for adults and children?
Can an 8-year-old pediatric patient take a 10 mg dose of montelukast (Singulair)?
What is the recommended duration of treatment with montelukast (singulair) 5 mg chewable tablet for a 12-year-old boy with a history of asthma or allergic rhinitis?
What is the dosage and administration of Monteleukast (Singulair) for asthma and seasonal allergic rhinitis?
When should a Complete Blood Count (CBC) be checked in a patient undergoing chemotherapy with capecitabine and oxaliplatin, and receiving filgrastim (Granulocyte-Colony Stimulating Factor (G-CSF)) to prevent neutropenia?
When is the best time to convert from an external fixator to an internal fixator for a patient with an open fracture of the tibia and soft tissue avulsion?
What causes dizziness in a patient after performing squats or squatting down, considering potential underlying conditions such as orthostatic hypotension, anemia, or cardiac issues?
What is the risk of damage to the Bulbocavernosus Reflex in an adult male with a history of anal fissure and possible sexual dysfunction undergoing fissureectomy, lateral sphincterotomy (lateral surgical cut of the anal sphincter), or hemorrhoidectomy surgery?
What is the recommended daily potassium intake from food for a patient with Stage 3B Chronic Kidney Disease (CKD), hyperkalemia, Type 2 Diabetes, gastritis, duodenitis, and Barrett's esophagus?
What is the most appropriate next step for a female patient with a long-standing history of pruritus and fatigue, presenting with jaundice, abdominal swelling, splenomegaly, ascites, and a 3 cm focal liver lesion, with lab results showing anemia (low Hemoglobin (Hb)), thrombocytopenia (low Platelets count), leukopenia (low White Blood Cell (WBC) count), coagulopathy (elevated International Normalized Ratio (INR)), and abnormal liver function tests (elevated Alkaline Phosphatase (ALP) and Transaminases (Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST)))?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.